Bharat Rasayan Limited

Bharat Rasayan Limited

976.40
INR
+0.90
(+0.09%)
86.21EPS
15.68P/E
22.47BMarket Cap
Bharat Rasayan Limited
NSE:BHARATRAS
(National Stock Exchange of India)

Recent

price

976.40

P/E

ratio

15.68

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
55.2
83.52
110.35
212.65
258.18
268.02
360.2
464.07
578.43
714.95
635.66
779.35
742.68
621.76
698.92
735.09
723.53
Revenue per Share
3.47
5.78
5.64
11.86
18.68
19.93
32.09
57.85
65.62
92.76
96.42
105.89
74.98
57.47
84.79
87.68
86.21
Basic EPS, GAAP
4.25
-20.12
-50.22
1.66
27.28
18.62
1.93
-7.15
-58.89
120.12
82.23
-72.91
114.21
8.43
82.02
35.2
- -
Free Cash Flow per Basic Share
0.45
0.3
0.3
- -
0.25
0.37
0.3
0.37
0.37
0.37
0.37
0.38
0.38
0.38
0.38
0.38
- -
Dividend per Share
25.73
31.15
36.79
48.36
66.57
86.5
118.1
175.49
240.55
331.93
427.94
463.28
537.46
594.36
679.86
766.94
- -
Book Value per Share
25.72
31.14
36.75
48.28
66.51
86.44
118.05
175.28
240.15
331.78
427.86
463.19
537.39
594.31
679.81
766.89
- -
Tangible Book Value per Share
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
Basic Weighted Avg Shares
938
1,419
1,876
3,614
4,388
4,555
6,122
7,887
9,831
12,151
10,804
12,953
12,343
10,334
11,617
12,218
12,026
Sales/Revenue/Turnover
5.19
10.47
9.87
12.63
14.52
13.95
15.46
18.04
17.36
16.85
19.85
17.5
13.88
8.89
12.75
14.15
12.45
Operating Margin (%)
19
16
70
179
178
171
165
165
171
219
258
249
260
258
270
264
270
Depreciation Expense
59
98
96
201
317
339
545
983
1,115
1,576
1,639
1,760
1,246
955
1,409
1,457
1,433
Net Income, GAAP
9.94
28.34
32.07
32.99
33.94
34.29
35.02
27.27
28.11
23.17
23.9
24.69
28.39
22.55
23.83
24.64
23.92
Effective Tax Rate (%)
6.28
6.93
5.11
5.57
7.24
7.44
8.91
12.46
11.34
12.97
15.17
13.59
10.1
9.24
12.13
11.93
11.92
Profit Margin (%)
215
-54
157
382
498
582
1,154
1,933
2,705
3,651
4,801
4,923
6,203
7,099
8,320
9,240
- -
Working Capital
- -
56
830
920
673
400
400
400
400
220
- -
10
- -
- -
- -
- -
- -
LT Debt
437
529
625
822
1,131
1,470
2,007
2,982
4,088
5,641
7,273
7,700
8,933
9,879
11,300
12,747
- -
Total Equity
9.69
14.48
6.71
9.61
13.26
12.84
18.23
27.69
22.18
23.73
22.25
19.48
12.73
7.14
9.87
9.3
- -
Return on Invested Capital (%)
13.13
14.75
6.71
14.59
17.8
15.99
21.19
28.67
22.71
25.82
23.09
20.95
13.81
9.83
12.66
11.98
- -
Return on Capital (%)
13.58
20.34
16.6
27.84
32.51
26.04
31.37
39.41
31.55
32.41
25.38
23.51
14.98
10.15
13.31
12.12
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
12
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
17
17
17
Market Capitalization
37,082
20,113
22,473

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
10,603
- -
Cash, Cash Equivalents & STI
- -
2,723
- -
Accounts Receivable, Net
- -
3,854
- -
Inventories
- -
3,306
- -
Total Current Liabilities
- -
1,363
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
12
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
24.88%
11.94%
12.81%
Free Cash Flow
10.79%
55.9%
-57.08%
Net Income, GAAP
20.58%
1.16%
3.41%
Sales/Revenue/Turnover
11.69%
3.3%
5.18%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
2,822
3,279
2,564
3,065
11,617
2026
3,774
2,860
2,705
3,080
12,218
2027
3,382
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
25.94
19.34
24.39
15.12
84.79
2026
23.86
16.78
24.08
22.95
87.68
2027
22.4
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.38
2026
- -
- -
- -
- -
0.38
2027
- -
- -
- -
- -
- -
Business
Bharat Rasayan Limited manufactures and sells technical grade pesticides and intermediates for the agrochemical industry in India. The company produces insecticides such as Lambda Cyhalothrin Technical, Thiamethoxam, Fipronil, Fluxametamide and Tolfenpyrad Technical; herbicides including Metribuzin Technical, Diuron Technical, Superfast, Farmaan and Funai; fungicides; and various chemical intermediates like Metaphenoxy Benzaldehyde, which serve as raw materials for pesticide formulations used in plant protection. Incorporated in 1989 and headquartered at 1501 Vikram Tower, Rajendra Place, New Delhi, India, it operates manufacturing facilities in Rohtak, Haryana, and Dahej, Gujarat; exports products via multinational agrochemical firms and traders; and targets formulating units in the agricultural inputs sector with top 10 products accounting for 66% of sales. In October 2025, the board approved a 1:2 stock split and 1:1 bonus issue to enhance liquidity, with a record date of December 12, 2025; the 36th AGM in September 2025 approved FY2024-25 accounts, a final dividend of INR 1.50 per share, and related party transactions up to INR 700 crore and INR 150 crore; quarterly results for June 2025 showed profit growth of 103% and sales up 34%.